SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ichikawa, Y.
Right arrow Articles by Arimori, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichikawa, Y.
Right arrow Articles by Arimori, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Serum Apolipoprotein H Levels in Systemic Lupus Erythematosus Are Not Influenced by Antiphospholipid Antibodies

Yukinobu Ichikawa

Department of Internal Medicine, Tokai University School of Medicine

Kazunaga Takamatsu

the Second Department of Internal Medicine, Kochi Medical School

Hiroaki Shimizu

Department of Internal Medicine, Tokai University School of Medicine

Mitsuaki Uchiyama

Department of Internal Medicine, Tokai University School of Medicine

Junko Moriuchi

Department of Internal Medicine, Tokai University School of Medicine

Masatoshi Takaya

Department of Internal Medicine, Tokai University School of Medicine

Nobumasa Kobayashi

Blood Transfusion Service Center, Tokai University Hospital

Tsutomu Kawada

Central Clinical Laboratory, Tokai University Hospital, Japan

Shigeru Arimori

Department of Internal Medicine, Tokai University School of Medicine

Anticardiolipin antibodies (aCL) were recently discovered to recognize a complex consisting of phospholipids and apolipoprotein H (apo H). In this study, we determined the serum apo H levels in 36 systemic lupus erythematosus (SLE) patients with or without antiphospholipid antibodies (aPL), including aCL and lupus anticoagulants, to clarify the possible effects of aPL on apo H levels in vivo.

The apo H levels were low in SLE patients as compared with 22 healthy controls. However, no associations were found between apo H levels and circulating aPL or clinical features of the antiphospholipid antibody syndrome. A secondary hyperlipidemic state, which probably related to lupus nephritis (proteinuria) and/or prednisolone treatment, increased apo H levels in SLE patients.

Key Words: Apolipoprotein H • ß2-Glycoprotein I • Antiphospholipid antibodies • Systemic lupus erythematosus

Lupus, Vol. 1, No. 3, 145-149 (1992)
DOI: 10.1177/096120339200100305
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
F Lin, R Murphy, B White, J Kelly, C Feighery, R Doyle, S Pittock, J Moroney, O Smith, W Livingstone, et al.
Circulating levels of {beta}2-glycoprotein I in thrombotic disorders and in inflammation
Lupus, February 1, 2006; 15(2): 87 - 93.
[Abstract] [PDF]

Home page
 LupusHome page
D. A. Kandiah and S. A. Krilis
Beta2-Glycoprotein I
Lupus, August 1, 1994; 3(4): 207 - 212.
[PDF]


Advertisement